
About Tanuk Pharma (India) Limited
Data last updated:
Tanuk Pharma (India) Limited is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 February 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PLC065899. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹8.5 Cr and a paid-up capital of ₹3.67 Cr. It is led by directors including Pankaj Kumar Thakur and Kidar Nath Bhalla.
Its last annual general meeting (AGM) was held on 25 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at A – 11 Kailash Apartments Lala Lajpatrai Marg, New Delhi, Delhi, India – 110048.
As per MCA filings, the company has open charges of ₹1.05 Cr and satisfied charges of ₹6 Cr on record. Court records list 13 cases involving the company, including 7 filed by the company and 6 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tanukpharma.com.
Company details
Contact details
Tanuk Pharma (India) Limited's registered office is in New Delhi, Delhi. Its website is tanukpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 11 Kailash Apartments Lala Lajpatrai Marg, New Delhi, Delhi, India – 110048
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Tanuk Pharma (India) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Tanuk Pharma (India) Limited
FY 2023 filings availableTanuk Pharma (India) Limited reported revenue of ₹235 (up 5% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 5% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 83%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹235 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tanuk Pharma (India) Limited, buy the company report.
Board of directors of Tanuk Pharma (India) Limited
Tanuk Pharma (India) has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lokesh Kumar Saxena Also directs: Midland Securetech Private Limited | Additional Director | 23 Nov 2023 | 2 Years 11 Months | Current |
| Pankaj Kumar Thakur | Director | 10 Aug 2016 | 10 Years 3 Months | Current |
| Kidar Nath Bhalla | Director | 02 Feb 2015 | 11 Years 9 Months | Current |
Peer comparison
Tanuk Pharma (India) Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aahaan Commercials Private Limited | ₹300 (FY 2019) | 33.0% | Mumbai, Maharashtra, India | |||
| Chittaranjan Pharma Private Limited | ₹264 (FY 2024) | -100.0% | Kolkata, West Bengal, India | |||
| Adorica Care Private Limited | ₹262 (FY 2025) | -100.0% | Greater Noida, Uttar Pradesh, India | |||
| Twin Shore Towers Private Limited | ₹252 (FY 2025) | Chennai, Tamil Nadu, India | ||||
| Medidaili Technologies Private Limited | ₹250 (FY 2019) | -100.0% | Malur, Karnataka, India | |||
| Tanuk Pharma (India) Limitedthis company | ₹235 (FY 2023) | 5.0% | New Delhi, Delhi, India | |||
| Boson Remedies Private Limited | ₹203 (FY 2024) | -100.0% | Ghaziabad, Uttar Pradesh, India | |||
| Walter Bushnell Healthsciences Private Limited | ₹192 (FY 2024) | -100.0% | Mohali, Punjab, India | |||
| Hospitrade Private Limited | ₹173 (FY 2023) | Ahmedabad, Gujarat, India | ||||
| Rudra Pharma Distributors Private Limited | ₹147 (FY 2019) | -100.0% | Mumbai, Maharashtra, India | |||
| Coral Healthcare Online Private Limited | ₹134 (FY 2025) | -100.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Tanuk Pharma (India) Limited, buy the company report.
Auditor
Tanuk Pharma (India) Limited is audited by BHUVI KANT & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHUVI KANT & ASSOCIATES | FY 2023 | 007798C |
Shareholding
The shareholding of Tanuk Pharma (India) Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tanuk Pharma (India) Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Mar 2015 | 10560192 | Housing Development Finance Corporation Limited | ₹70 Lakh | Open | |
| 19 Sep 2011 | 10308925 | Standard Chartered Bank | ₹34.5 Lakh | Open | |
| 16 May 2014 | 10500350 | Bank of Baroda | ₹3.25 Cr | Satisfied | |
| 10 Feb 1997 | 90056668 | Punjab National Bank | ₹2.75 Cr | Satisfied |
To see the full charge records of Tanuk Pharma (India) Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Tanuk Pharma (India) Limited has 13 court cases on record: 7 filed by Tanuk Pharma (India), 6 filed against it. 1 case is pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 3 | 1 |
| High courts | 3 | 1 | 0 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Dehradun, Uttarakhand | Criminal case | Filed by the company against M/S Lodrs Creative Infrasolution Pvt. Ltd. | Pending |
| Supreme Court | Court case (1431-Criminal Matters : Matters challenging prosecution under Negotiable Instruments Act) | Filed against the company by M/S Lords Creative Infra Solutions Pvt. Ltd. Through Its Director A Company Incorporated Under the Indian Companies Act, 1913 Registered Office at 1207, Best Sky Tower, Netaji Subhash Place , , Delhi and 1 other | Disposed |
| District court, Dehradun, Uttarakhand | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
| High Court of Uttarakhand | Court case (C482) | Filed against the company | Disposed |
| District court, New Delhi, Delhi | Appeal | Filed against the company by an individual | Disposed |
To see the full case history of Tanuk Pharma (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tanuk Pharma (India) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tanuk Pharma (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Tanuk Pharma (India) Limited, buy the company report.
Recent activity
Tanuk Pharma (India) Limited has 8 board changes on record since 2015: 3 appointments and 5 cessations. The latest: Anuradha Bhalla ceased to be Director on 28 Nov 2023.
6 earlier events are in the company report.
Frequently asked questions
Tanuk Pharma (India) is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 February 1995 (31+ years old) and is registered under CIN U74899DL1995PLC065899.
Tanuk Pharma (India) has 3 current directors:
- Lokesh Kumar Saxena - Additional Director
- Pankaj Kumar Thakur - Director
- Kidar Nath Bhalla - Director
The latest financial statements of Tanuk Pharma (India) on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 25 September 2023. Year-wise statements from 2015 are in the company report.
No. Tanuk Pharma (India) has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Tanuk Pharma (India) is U74899DL1995PLC065899. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tanuk Pharma (India) has 13 court cases on record: 7 filed by the company and 6 filed against it. 1 is pending. Most are in the district courts.
Tanuk Pharma (India) was incorporated on 28 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Tanuk Pharma (India) by revenue are Aahaan Commercials Private Limited, Chittaranjan Pharma Private Limited, Adorica Care Private Limited, Twin Shore Towers Private Limited, Medidaili Technologies Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Anuradha Bhalla ceased to be Director on 28 Nov 2023. Tarun Bhalla ceased to be Director on 28 Nov 2023. Lokesh Kumar Saxena was appointed as Additional Director on 23 Nov 2023. Tanuk Pharma (India) has 8 board changes on record in total.
Tanuk Pharma (India) can be reached through the website tanukpharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Tanuk Pharma (India) is at A – 11 Kailash Apartments Lala Lajpatrai Marg, New Delhi, Delhi, India – 110048.

